Skip to content
Screener

Roivant Sciences ROIV Interest Income

Interest Income at other companies

Moderna logo
ModernaMRNA
$67M-17.3%
Regenxbio logo
RegenxbioRGNX
$1.22M-63.8%
CNT
Canton Strategic HoldingsCNTN
$318.18K+2,268%
Revvity logo
RevvityRVTY
$6.3M-37.5%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$2.43M-3.3%

Segments

By segment

See full
Reportable Segment$36.92M-23.6%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Loss from operations(365,993)(284,922)
Change in fair value of investments(36,637)19,125
Change in fair value of liability instruments2,329
Interest income(36,922)(48,322)
Other expense, net2,13011,208
Loss before income taxes(294,564)(269,262)
Income tax (benefit) expense(3,958)4,649
Net loss(290,606)(273,911)

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's interest income?
Roivant Sciences (ROIV) reported interest income of $36.92M in Q2 2026.
How has Roivant Sciences's interest income changed year-over-year?
Roivant Sciences's interest income decreased by 23.6% year-over-year, from $48.32M to $36.92M.
What is the long-term trend for Roivant Sciences's interest income?
Over 2 years (2023 to 2025), Roivant Sciences's interest income has grown at a 10.3% compound annual growth rate (CAGR), from $146.43M to $178.11M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Roivant Sciences's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude